Contribuciones del usuario AHUS Expert Group
Para AHUS Expert Group discusión registro de bloqueos subidas registros cuentas globales registro del filtro antiabusos
Usuario con 4 ediciones. Cuenta creada el 3 nov 2014.
4 nov 2014
- 13:1713:17 4 nov 2014 difs. hist. −1 m Usuario:AHUS Expert Group/Síndrome hemolítico urémico atípico (SHUa) Sin resumen de edición
- 13:1613:16 4 nov 2014 difs. hist. +111 Usuario:AHUS Expert Group/Síndrome hemolítico urémico atípico (SHUa) This article was prepared in English by the aHUS Expert group. Dr Vega Cabrera contributed to the Spanish elaboration. Editorial support was provided by Physicians World Europe, financial support by Alexion Pharmaceuticals, maker of Eculizumab.
- 09:2309:23 4 nov 2014 difs. hist. +30 622 N Usuario:AHUS Expert Group/Síndrome hemolítico urémico atípico (SHUa) The writing of this article from November 4, 2014 was financially supported by Alexion Pharmaceuticals, the maker of eculizumab. Dr. S. Yüksel, Dr C. Vega, Prof N. Kozlo have contributed to the elaboration of this page posted on November 14, 2014. Etiqueta: posible promocional